This first open access European CAR-T Handbook, co-promoted by the European Society for Blood and Marrow Transplantation (EBMT) and the European Hematology Association (EHA), covers several aspects of CAR-T cell treatments, including the underlying biology, indications, management of side-effects, access and manufacturing issues. This book, written by leading experts in the field to enhance readers’ knowledge and practice skills, provides an unparalleled overview of the CAR-T cell technology and its application in clinical care, to enhance readers’ knowledge and practice skills
Hematopoietic-cell transplantation (HCT) is widely used for acquired and congenital disorders of the...
Chimeric Antigen Receptor T (CAR-T) cells are certainly an important therapy for patients with relap...
CAR T-cells are autologous or allogeneic human lymphocytes that are genetically engineered to expres...
This first open access European CAR-T Handbook, co-promoted by the European Society for Blood and Ma...
This Open Access edition of the European Society for Blood and Marrow Transplantation (EBMT) handboo...
Background Several commercial and academic autologous chimeric antigen receptor T-cell (CAR-T) pr...
The ongoing development of novel personalized cancer therapies has resulted in the implementation of...
Chimeric antigen receptor T cells (CAR-T cells) are a novel form of cellular immunotherapy for patie...
There is an increasing reliance on modern cancer therapies on immunotherapeutic approaches such as i...
Purpose of review With the approval of the first chimeric antigen receptor (CAR)-T cell ...
Chimeric antigen receptor T (CAR-T) cell therapy is a novel therapeutic modality for acute lymphobla...
CAR-T cells are a promising new therapy that offer significant advantages compared with conventional...
Background: Adoptive therapy with genetically modified T cells achieves spectacular remissions in ad...
Chimeric antigen receptor T-cells (CAR-T cells) are a new modality of oncological treatment which ha...
Rapid developments in the field of CAR T cells offer important new opportunities while at the same t...
Hematopoietic-cell transplantation (HCT) is widely used for acquired and congenital disorders of the...
Chimeric Antigen Receptor T (CAR-T) cells are certainly an important therapy for patients with relap...
CAR T-cells are autologous or allogeneic human lymphocytes that are genetically engineered to expres...
This first open access European CAR-T Handbook, co-promoted by the European Society for Blood and Ma...
This Open Access edition of the European Society for Blood and Marrow Transplantation (EBMT) handboo...
Background Several commercial and academic autologous chimeric antigen receptor T-cell (CAR-T) pr...
The ongoing development of novel personalized cancer therapies has resulted in the implementation of...
Chimeric antigen receptor T cells (CAR-T cells) are a novel form of cellular immunotherapy for patie...
There is an increasing reliance on modern cancer therapies on immunotherapeutic approaches such as i...
Purpose of review With the approval of the first chimeric antigen receptor (CAR)-T cell ...
Chimeric antigen receptor T (CAR-T) cell therapy is a novel therapeutic modality for acute lymphobla...
CAR-T cells are a promising new therapy that offer significant advantages compared with conventional...
Background: Adoptive therapy with genetically modified T cells achieves spectacular remissions in ad...
Chimeric antigen receptor T-cells (CAR-T cells) are a new modality of oncological treatment which ha...
Rapid developments in the field of CAR T cells offer important new opportunities while at the same t...
Hematopoietic-cell transplantation (HCT) is widely used for acquired and congenital disorders of the...
Chimeric Antigen Receptor T (CAR-T) cells are certainly an important therapy for patients with relap...
CAR T-cells are autologous or allogeneic human lymphocytes that are genetically engineered to expres...